Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
Clinical trial NCT06476132 · RECRUITING
Trial details
- NCT number
- NCT06476132
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-12
- Primary completion
- 2027-05-30
- Enrollment
- 234
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.